FDA Panel Backs Safety Of Infant Cooling Cap To Avert Brain Damage
This article was originally published in The Gray Sheet
Executive Summary
Olympic Medical should maintain a post-approval registry to identify a more distinct treatment population to receive the firm's Cool-Cap hypoxic-ischemic encephalopathy (HIE) device, according to FDA's Neurological Devices Panel